Stomach function enhancement

Stomach function enhancement" describes the augmentation of normal physiological processes of the stomach, such as increased motility (movement), improved gastric emptying, or stimulated secretion, but is not itself a molecule, protein, enzyme, or receptor amenable to direct pharmacological targeting. Instead, clinical strategies to enhance stomach function focus on modulating the activity of specific gastric or enteric targets—including receptors such as serotonin 5-HT4 receptor, dopamine D2 receptor, motilin receptor, and others—using drugs described as 'prokinetic' or 'promotility' agents. Drug development in this area involves identifying molecular targets that can stimulate appropriate muscle contractions or secretory functions, but "stomach function enhancement" itself is a descriptive goal rather than a molecular entity or direct therapeutic target[1].

Other names

Gastric function enhancementGastric motility enhancementImproved stomach function